Teijin Pharma Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Teijin Pharma Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Teijin Pharma Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Teijin Pharma Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
27 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Teijin Pharma Limited (Teijin Pharma), a subsidiary of Teijin Limited is a pharmaceutical company that develops, manufactures and markets pharmaceutical and home healthcare solutions. The company offers a wide range of pharmaceutical products for treating bone and joint diseases, respiratory diseases and cardiovascular and metabolic diseases. Its pharmaceutical products comprise inhaled corticosteroid for asthma, osteoporosis drugs, anti-hyperuricemia agent, proprietary drugs to treat metabolic disorders; and percutaneous patch preparation for dilating coronary arteries in patients with angina/myocardial infarction.

Teijin Pharma Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals

  
Source:
Document ID
GDPH24061D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Teijin Pharma Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Teijin Pharma Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Teijin Pharma Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Teijin Pharma Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Teijin Pharma Limited, Medical Devices Deals, 2010 to YTD 201691
Teijin Pharma Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016101
Teijin Pharma Limited, Pharmaceuticals &Healthcare, Deal Details1113
  Partnerships111
    Teijin Pharma Enters into Discovery Agreement with PeptiDream111
    Teijin Pharma And Amgen Enter Into R&D Agreement To Develop Autoimmune Disease Therapies121
    Teijin Pharma Extends Co-Marketing Agreement With Menarini For TMX-67131
    NovAliX Enters Into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma141
    Teijin Pharma Enters Into Distribution Agreement With Astellas Pharma For Febuxostat151
    Teijin Pharma Enters Into Co-Marketing Agreement With Takeda Pharma North America For TMX-67161
    Teijin Pharma Enters Into Co-Marketing Agreement With Algorithm For TMX-67171
    Teijin Pharma Enters Into Co-Marketing Agreement With Menarini Group For TMX-67181
  Licensing Agreements191
    Teijin Pharma Enters into Licensing Agreement with Versartis192
    Teijin Pharma Enters Into Licensing Agreement With Pulmagen Therapeutics For ADC3680211
    Teijin Pharma Enters Into An Agreement With Astellas Pharma222
Teijin Pharma Limited - Key Competitors241
Key Employees251
Locations And Subsidiaries261
  Head Office261
  Other Locations &Subsidiaries261
Appendix271
  Methodology271
  About GlobalData271
  Contact Us271
  Disclaimer271

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Teijin Pharma Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Teijin-Pharma-Limited-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7747>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Teijin Pharma Limited - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Teijin-Pharma-Limited-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7747>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research